You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Melatonin and the Prevention and Management of Delirium: A Scoping Study
|
|---|---|
| Published in |
Frontiers in Medicine, January 2018
|
| DOI | 10.3389/fmed.2017.00242 |
| Pubmed ID | |
| Authors |
Sin Wei Choy, Aun Chian Yeoh, Zhao Zheng Lee, Velandai Srikanth, Chris Moran |
| Abstract |
The therapeutic benefit of melatonin in the prevention and treatment of delirium is uncertain. To perform a scoping study to describe the existing literature regarding the use of melatonin and ramelteon in the prevention and treatment of delirium. We performed a scoping study using the Arksey and O'Malley framework to explore our objective. Two independent panels searched MEDLINE, OVID, EMBASE, PubMed, Google Scholar, and Cochrane Library for relevant articles up to November 2017 describing the use of melatonin and ramelteon in the prevention or management of delirium. We extracted relevant summary data from the studies and attempted to draw conclusion regarding benefit. We summarized evidence from 20 relevant articles. There were a total of nine articles: five randomized controlled trials (RCTs), two retrospective medical record reviews, one non-randomized observational study, and one case report describing the role of either melatonin or ramelteon in preventing delirium. There were a total of 11 studies studying the role of either melatonin or ramelteon in the management of established delirium. None of these were RCT and were predominantly case series and case reports. Four of the five trials studying the effect of melatonin analogs in preventing delirium reported a beneficial effect but study heterogeneity limited any broad recommendations. Similarly, the lack of any well-designed trials limits any recommendations regarding the effect of melatonin analogs in treating delirium. Large, well-designed clinical trials are required to explore the potential beneficial effects of melatonin and ramelteon on delirium prevention and management. |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 20% |
| United Kingdom | 4 | 20% |
| United States | 3 | 15% |
| Canada | 1 | 5% |
| Brazil | 1 | 5% |
| New Zealand | 1 | 5% |
| Chile | 1 | 5% |
| Saudi Arabia | 1 | 5% |
| Switzerland | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 3 | 15% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 50% |
| Practitioners (doctors, other healthcare professionals) | 7 | 35% |
| Scientists | 3 | 15% |
Mendeley readers
The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 46 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 9 | 20% |
| Researcher | 7 | 15% |
| Other | 6 | 13% |
| Student > Ph. D. Student | 5 | 11% |
| Student > Master | 5 | 11% |
| Other | 9 | 20% |
| Unknown | 5 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 20 | 43% |
| Nursing and Health Professions | 7 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 9% |
| Neuroscience | 2 | 4% |
| Social Sciences | 2 | 4% |
| Other | 5 | 11% |
| Unknown | 6 | 13% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2018.
All research outputs
#3,455,189
of 25,826,146 outputs
Outputs from Frontiers in Medicine
#1,016
of 7,334 outputs
Outputs of similar age
#72,836
of 452,801 outputs
Outputs of similar age from Frontiers in Medicine
#20
of 86 outputs
Altmetric has tracked 25,826,146 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,334 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 452,801 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.